To include your compound in the COVID-19 Resource Center, submit it here.

Melimmune-1 and -2 therapeutic vaccine data

At the First International Conference on Engineered Vaccines for Cancer and AIDS in San Francisco, IDPH reported results from Phase I/II tests of Melimmune-2 alone

Read the full 259 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE